glp-1 receptor agonist Agonists – Peripheral Brain GLP-1 Receptor Agonists as Treatments
Description
doi: 10.1016/j.eclinm.2023.101882
For the groups randomized to placebo, 1.2 mg of pemvidutide, 1.8 mg, and 2.4 mg,, week-24 absolute reduction in liver volume, which is linked to overall mortality, was 3.3%, 12.6%, 19.1%, and 18.0%
Importantly, GLP-1RA therapies are no longer viewed solely as glucose-lowering drugs but as comprehensive cardiometabolic treatments
The FDA has been clear on this
So bleibst du aktiv, fit und ready fr jeden Tag
